Literature DB >> 15804240

The epidemiology of epilepsy in Europe - a systematic review.

L Forsgren1, E Beghi, A Oun, M Sillanpää.   

Abstract

Population-based epidemiological studies on epilepsy are available mainly from the UK and the Nordic, Baltic and western Mediterranean countries. No studies were identified from large areas of Europe, especially from the former eastern Europe (except the Baltic countries) and the eastern Mediterranean countries. Based on the prevalence of epilepsy in different studies and accounting for incomplete case identification the estimated number of children and adolescents in Europe with active epilepsy is 0.9 million (prevalence 4.5-5.0 per 1000), 1.9 million in ages 20-64 years (prevalence six per 1000) and 0.6 million in ages 65 years and older (prevalence seven per 1000). Approximately 20-30% of the epilepsy population have more than one seizure per month. Based on the age-specific incidence rates in European studies, the estimated number of new cases per year amongst European children and adolescents is 130,000 (incidence rate 70 per 100,000), 96,000 in adults 20-64 years (incidence rate 30 per 100,000) and 85,000 in the elderly 65 years and older (incidence 100 per 100,000). The proportion of both new and established cases with epilepsy in the young, adults and elderly in individual countries may differ substantially from total European distribution because of differences in age structure.

Entities:  

Mesh:

Year:  2005        PMID: 15804240     DOI: 10.1111/j.1468-1331.2004.00992.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  153 in total

Review 1.  Control of excessive neural circuit excitability and prevention of epileptic seizures by endocannabinoid signaling.

Authors:  Yuki Sugaya; Masanobu Kano
Journal:  Cell Mol Life Sci       Date:  2018-05-08       Impact factor: 9.261

Review 2.  Deep brain and cortical stimulation for epilepsy.

Authors:  Mathieu Sprengers; Kristl Vonck; Evelien Carrette; Anthony G Marson; Paul Boon
Journal:  Cochrane Database Syst Rev       Date:  2017-07-18

Review 3.  Epilepsy: recent advances.

Authors:  Dora A Lozsadi; Joachim Von Oertzen; Hannah R Cock
Journal:  J Neurol       Date:  2010-09-25       Impact factor: 4.849

4.  Challenges of epidemiological research on epilepsy in resource-poor countries.

Authors:  Fabrice Quet; Peter Odermatt; Pierre-Marie Preux
Journal:  Neuroepidemiology       Date:  2008-01-17       Impact factor: 3.282

Review 5.  Is epilepsy a preventable disorder? New evidence from animal models.

Authors:  Kathryn A Giblin; Hal Blumenfeld
Journal:  Neuroscientist       Date:  2010-06       Impact factor: 7.519

6.  Effects of an acute seizure on associative learning and memory.

Authors:  Andrew J Holley; Joaquin N Lugo
Journal:  Epilepsy Behav       Date:  2015-12-03       Impact factor: 2.937

7.  Attitudes towards African traditional medicine and Christian spiritual healing regarding treatment of epilepsy in a rural community of northern Tanzania.

Authors:  Andrea Sylvia Winkler; Michael Mayer; Michael Ombay; Bartholomayo Mathias; Erich Schmutzhard; Louise Jilek-Aall
Journal:  Afr J Tradit Complement Altern Med       Date:  2009-12-30

8.  Disparities in epilepsy surgery in the United States of America.

Authors:  Iván Sánchez Fernández; Christopher Stephen; Tobias Loddenkemper
Journal:  J Neurol       Date:  2017-07-12       Impact factor: 4.849

9.  Global campaign against epilepsy: assessment of a demonstration project in rural China.

Authors:  Wenzhi Wang; Jianzhong Wu; Xiuying Dai; Guangyu Ma; Bin Yang; Taiping Wang; Chenglin Yuan; Ding Ding; Zhen Hong; Patrick Kwan; Gail S Bell; Leonid L Prilipko; Hanneke M de Boer; Josemir W Sander
Journal:  Bull World Health Organ       Date:  2008-12       Impact factor: 9.408

10.  Incidence of epilepsy in Ferrara, Italy.

Authors:  Edward Cesnik; Francesco Pedelini; Raffaella Faggioli; Vincenza Cinzia Monetti; Enrico Granieri; Ilaria Casetta
Journal:  Neurol Sci       Date:  2013-04-26       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.